Neurocrine Biosciences | 현금 및 동등한



Cash And Equivalent 변화 날짜
AbbVie USD 5.52B 1.73B 2024-12
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Cytokinetics USD 94.86M 47.97M 2024-12
Dynavax Technologies USD 95.88M 23.45M 2024-12
Exelixis USD 217.37M 40.97M 2025-01
Gilead Sciences USD 7.93B 2.06B 2025-03
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pfizer USD 1.43B 387M 2025-03
Prothena USD 471.39M 47.87M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Repligen USD 697.23M 60.13M 2025-03
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Neurocrine Biosciences 현금 및 동등한 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2025.